Dr. Christine Allen is CEO and co-founder of Intrepid Labs Inc., a company leveraging AI, automation, and deep pharmaceutical expertise to accelerate drug formulation and develop proprietary delivery technologies. Intrepid’s approach helps bring transformative medicines to patients faster, improving therapeutic outcomes and enhancing patient care.

Christine is also a full professor at the University of Toronto (U of T), internationally recognized for her contributions to drug formulation and development, with over 180 peer-reviewed publications. She is a distinguished fellow of both the American Institute for Medical and Biological Engineering and the Canadian Academy of Health Sciences. Christine has held significant leadership roles, including President of both the Controlled Release Society and the Canadian Society for Pharmaceutical Sciences, and Editor-in- Chief of the Journal of Controlled Release.

Her academic leadership includes serving as the inaugural Associate Vice-President and Vice Provost Strategic Initiatives and Interim Dean of the Leslie Dan Faculty of Pharmacy at U of T.